Abstract
Complex biological processes, such as inflammation and cancer, rely on the crosstalk and activation of distinct cellular networks that control gene expression. Central to this process is the transcription factor NF-κB. In this chapter, we focus on the role of the atypical protein kinase C (PKC) isoforms (aPKC) in inflammation and cancer through the activation of this transcription factor in vivo. The aPKCs are key members of a network of kinases, adapters and regulators, such as p62 and Par-4, which confer functional plasticity and specificity to this critical pathway. Here, we summarize the molecular mechanisms that govern that network, learnt from the knock-out mouse models, to unravel its role and function in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amsen, D., Blander, J. M., Lee, G. R., Tanigaki, K., Honjo, T., & Flavell, R. A. (2004). Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell, 117, 515–526.
Ancrile, B., Lim, K. H., & Counter, C. M. (2007). Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes and Development, 21, 1714–1719.
Anest, V., Hanson, J. L., Cogswell, P. C., Steinbrecher, K. A., Strahl, B. D., & Baldwin, A. S. (2003). A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature, 423, 659–663.
Anrather, J., Csizmadia, V., Soares, M. P., & Winkler, H. (1999). Regulation of NF-kappaB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Czeta in primary endothelial cells. The Journal of Biological Chemistry, 274, 13594–13603.
Arsura, M., Mercurio, F., Oliver, A. L., Thorgeirsson, S. S., & Sonenshein, G. E. (2000). Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Molecular and Cellular Biology, 20, 5381–5391.
Avila, A., Silverman, N., Diaz-Meco, M. T., & Moscat, J. (2002). The Drosophila atypical protein kinase C-ref(2)p complex constitutes a conserved module for signaling in the toll pathway. Molecular and Cellular Biology, 22, 8787–8795.
Barradas, M., Monjas, A., Diaz-Meco, M.T., Serrano, M., & Moscat, J. (1999). The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. The EMBO Journal, 18, 6362–6369.
Berra, E., Diaz-Meco, M. T., Dominguez, I., Municio, M. M., Sanz, L., Lozano, J., et al. (1993). Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell, 74, 555–563.
Betschinger, J., Mechtler, K., & Knoblich, J. A. (2003). The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl. Nature, 422, 326–330.
Bos, J. L. (1989). Ras oncogenes in human cancer: A review. Cancer Research, 49, 4682–4689.
Cai, Y., Yu, F., Lin, S., Chia, W., & Yang, X. (2003). Apical complex genes control mitotic spindle geometry and relative size of daughter cells in Drosophila neuroblast and pI asymmetric divisions. Cell, 112, 51–62.
Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R., Schmidt, E. V., et al. (2001). IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell, 107, 763–775.
Chang, L., Kamata, H., Solinas, G., Luo, J. L., Maeda, S., Venuprasad, K., et al. (2006). The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell, 124, 601–613.
Chen, Z. J. (2005). Ubiquitin signalling in the NF-kappaB pathway. Nature Cell Biology, 7, 758–765.
Chen, L. F., & Greene, W. C. (2004). Shaping the nuclear action of NF-kappaB. Nature Reviews. Molecular Cell Biology, 5, 392–401.
Claudio, E., Brown, K., Park, S., Wang, H., & Siebenlist, U. (2002). BAFF-induced NEMO-independent processing of NF-kappaB2 in maturing B cells. Nature Immunology, 3, 958–965.
Cox, D. N., Seyfried, S. A., Jan, L. Y., & Jan, Y. N. (2001). Bazooka and atypical protein kinase C are required to regulate oocyte differentiation in the Drosophila ovary. Proceedings of the National Academy of Sciences of the United States of America, 98, 14475–14480.
Dejardin, E., Droin, N. M., Delhase, M., Haas, E., Cao, Y., Makris, C., et al. (2002). The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity, 17, 525–535.
Diaz-Meco, M. T., Berra, E., Municio, M. M., Sanz, L., Lozano, J., Dominguez, I., et al. (1993). A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation. Molecular and Cellular Biology, 13, 4770–4775.
Diaz-Meco, M. T., Lallena, M. J., Monjas, A., Frutos, S., & Moscat, J. (1999). Inactivation of the Inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. The Journal of Biological Chemistry, 274, 19606–19612.
Diaz-Meco, M. T., Lozano, J., Municio, M. M., Berra, E., Frutos, S., Sanz, L., et al. (1994). Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. The Journal of Biological Chemistry, 269, 31706–31710.
Diaz-Meco, M. T., Municio, M. M., Frutos, S., Sanchez, P., Lozano, J., Sanz, L., et al. (1996). The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell, 86, 777–786.
Dominguez, I., Diaz-Meco, M. T., Municio, M. M., Berra, E., Garcia de Herreros, A., Cornet, M. E., et al. (1992). Evidence for a role of protein kinase C zeta subspecies in maturation of Xenopus laevis oocytes. Molecular and Cellular Biology, 12, 3776–3783.
Dominguez, I., Sanz, L., Arenzana-Seisdedos, F., Diaz-Meco, M. T., Virelizier, J. L., & Moscat, J. (1993). Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes. Molecular and Cellular Biology, 13, 1290–1295.
Downward, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nature Reviews. Cancer, 3, 11–22.
Duran, A., Diaz-Meco, M. T., & Moscat, J. (2003). Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. The EMBO Journal, 22, 3910–3918.
Duran, A., Linares, J. F., Galvez, A. S., Wikenheiser, K., Flores, J. M., Diaz-Meco, M. T., et al. (2008). The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell, 13, 343–354.
Duran, A., Rodriguez, A., Martin, P., Serrano, M., Flores, J. M., Leitges, M., et al. (2004a). Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cell-mediated hepatitis. The EMBO Journal, 23, 4595–4605.
Duran, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., et al. (2004b). The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Developmental Cell, 6, 303–309.
Etienne-Manneville, S., & Hall, A. (2003). Cell polarity: Par6, aPKC and cytoskeletal crosstalk. Current Opinion in Cell Biology, 15, 67–72.
Farese, R. V., Sajan, M. P., Yang, H., Li, P., Mastorides, S., Gower, W. R., Jr., et al. (2007). Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. The Journal of Clinical Investigation, 117, 2289–2301.
Fields, A. P., & Murray, N. R. (2008). Protein kinase C isozymes as therapeutic targets for treatment of human cancers. Advances in Enzyme Regulation, 48, 166–178.
Fisher, G. H., Wellen, S. L., Klimstra, D., Lenczowski, J. M., Tichelaar, J. W., Lizak, M. J., et al. (2001). Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes and Development, 15, 3249–3262.
Galvez, A. S., Duran, A., Linares, J. F., Pathrose, P., Castilla, E. A., Abu-Baker, S., et al. (2009). Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Molecular and Cellular Biology, 29, 104–115.
Gao, T., Toker, A., & Newton, A. C. (2001). The carboxyl terminus of protein kinase c provides a switch to regulate its interaction with the phosphoinositide-dependent kinase, PDK-1. The Journal of Biological Chemistry, 276, 19588–19596.
Garcia-Cao, I., Duran, A., Collado, M., Carrascosa, M. J., Martin-Caballero, J., Flores, J. M., et al. (2005). Tumour-suppression activity of the proapoptotic regulator Par4. EMBO Reports, 6, 577–583.
Garcia-Cao, I., Lafuente, M., Criado, L., Diaz-Meco, M., Serrano, M., & Moscat, J. (2003). Genetic inactivation of Par4 results in hyperactivation of NF-kB and impairment of JNK and p38. EMBO Reports, 4, 307–312.
Ghosh, S., & Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell, 109(Suppl), S81–S96.
Goto, A., Blandin, S., Royet, J., Reichhart, J. M., & Levashina, E. A. (2003). Silencing of Toll pathway components by direct injection of double-stranded RNA into Drosophila adult flies. Nucleic Acids Research, 31, 6619–6623.
Grabiner, B. C., Blonska, M., Lin, P. C., You, Y., Wang, D., Sun, J., et al. (2007). CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes and Development, 21, 984–996.
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285–296.
Grivennikov, S., & Karin, M. (2008). Autocrine IL-6 signaling: A key event in tumorigenesis? Cancer Cell, 13, 7–9.
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57–70.
Ho, I. C., & Glimcher, L. H. (2002). Transcription: Tantalizing times for T cells. Cell, 109(Suppl), S109–S120.
Hoffmann, J. A. (2003). The immune response of Drosophila. Nature, 426, 33–38.
Jaruga, B., Hong, F., Sun, R., Radaeva, S., & Gao, B. (2003). Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: Up-regulating eotaxins and IL-5 and recruiting leukocytes. Journal of Immunology, 171, 3233–3244.
Joshi, J., Fernandez-Marcos, P. J., Galvez, A., Amanchy, R., Linares, J. F., Duran, A., et al. (2008). Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis. The EMBO Journal, 27, 2181–2193.
Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120, 649–661.
Karin, M. (1998). The NF-kappa B activation pathway: Its regulation and role in inflammation and cell survival. The Cancer Journal from Scientific American, 4(Suppl 1), S92–S99.
Karin, M. (2006). Nuclear factor-[kappa]B in cancer development and progression. Nature, 441, 431–436.
Karin, M., Cao, Y., Greten, F. R. and Li, Z. W. (2002). NF-kappaB in cancer: From innocent bystander to major culprit. Nature Reviews. Cancer, 2, 301–310.
Karin, M., Lawrence, T., & Nizet, V. (2006). Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer. Cell, 124, 823–835.
Karin, M., & Lin, A. (2002). NF-kappaB at the crossroads of life and death. Nature Immunology, 3, 221–227.
Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., French, D. M., et al. (2002). BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity, 17, 515–524.
Krummel, M. F., & Macara, I. (2006). Maintenance and modulation of T cell polarity. Nature Immunology, 7, 1143–1149.
Lafuente, M. J., Martin, P., Garcia-Cao, I., Diaz-Meco, M. T., Serrano, M., & Moscat, J. (2003). Regulation of mature T lymphocyte proliferation and differentiation by Par-4. The EMBO Journal, 22, 4689–4698.
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., & Karin, M. (2005). IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature, 434, 1138–1143.
Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., Garcia, J. F., et al. (2001). Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Molecular Cell, 8, 771–780.
Li, Q., & Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nature Reviews. Immunology, 2, 725–734.
Ludford-Menting, M. J., Oliaro, J., Sacirbegovic, F., Cheah, E. T., Pedersen, N., Thomas, S. J., et al. (2005). A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation. Immunity, 22, 737–748.
Luo, J. L., Kamata, H., & Karin, M. (2005). IKK/NF-kappaB signaling: Balancing life and death – a new approach to cancer therapy. The Journal of Clinical Investigation, 115, 2625–2632.
Luster, A. D., & Tager, A. M. (2004). T-cell trafficking in asthma: Lipid mediators grease the way. Nature Reviews. Immunology, 4, 711–724.
Macara, I. G. (2004). Par proteins: Partners in polarization. Current Biology, 14, R160–R162.
Maeda, S., Chang, L., Li, Z. W., Luo, J. L., Leffert, H., & Karin, M. (2003). IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity, 19, 725–737.
Maeda, S., Kamata, H., Luo, J. L., Leffert, H., & Karin, M. (2005). IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell, 121, 977–990.
Martin, P., Diaz-Meco, M. T., & Moscat, J. (2006). The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation. The EMBO Journal, 25, 3524–3533.
Martin, P., Duran, A., Minguet, S., Gaspar, M. L., Diaz-Meco, M. T., Rennert, P., et al. (2002). Role of zeta PKC in B-cell signaling and function. The EMBO Journal, 21, 4049–4057.
Martin, P., Villares, R., Rodriguez-Mascarenhas, S., Zaballos, A., Leitges, M., Kovac, J., et al. (2005). Control of T helper 2 cell function and allergic airway inflammation by PKC{zeta}. Proceedings of the National Academy of Sciences of the United States of America, 102, 9866–9871.
Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., et al. (1997). Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science, 278, 1812–1815.
Misra, R. S., Russell, J. Q., Koenig, A., Hinshaw-Makepeace, J. A., Wen, R., Wang, D., et al. (2007). Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappa B adaptors during T cell activation. The Journal of Biological Chemistry, 282, 19365–19374.
Moreno-Bueno, G., Fernandez-Marcos, P. J., Collado, M., Tendero, M. J., Rodriguez-Pinilla, S. M., Garcia-Cao, I., et al. (2007). Inactivation of the candidate tumor suppressor par-4 in endometrial cancer. Cancer Research, 67, 1927–1934.
Moscat, J., & Diaz-Meco, M. T. (2000). The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Reports, 1, 399–403.
Moscat, J., Diaz-Meco, M. T., Albert, A., & Campuzano, S. (2006a). Cell signaling and function organized by PB1 domain interactions. Molecular Cell, 23, 631–640.
Moscat, J., Diaz-Meco, M. T., & Rennert, P. (2003). NF-kappaB activation by protein kinase C isoforms and B-cell function. EMBO Reports, 4, 31–36.
Moscat, J., Rennert, P., & Diaz-Meco, M. T. (2006b). PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death and Differentiation, 13, 702–711.
Mosmann, T. R., & Coffman, R. L. (1989). TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology, 7, 145–173.
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J. H., Xue, X., & Okumura, K. (2006). Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death and Differentiation, 13, 730–737.
Nalca, A., Qiu, S. G., El-Guendy, N., Krishnan, S., & Rangnekar, V. M. (1999). Oncogenic Ras sensitizes cells to apoptosis by Par-4. The Journal of Biological Chemistry, 274, 29976–29983.
Naugler, W. E., & Karin, M. (2008). NF-kappaB and cancer-identifying targets and mechanisms. Current Opinion in Genetics and Development, 18, 19–26.
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., et al. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science, 317, 121–124.
Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. The FASEB Journal, 9, 484–496.
O’Shea, J. J., Gadina, M., & Schreiber, R. D. (2002). Cytokine signaling in 2002: New surprises in the Jak/Stat pathway. Cell, 109(Suppl), S121–S131.
Ohno, S. (2001). Intercellular junctions and cellular polarity: The PAR–aPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Current Opinion in Cell Biology, 13, 641–648.
Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H. R., Zhang, Y., & Wrana, J. L. (2005). Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science, 307, 1603–1609.
Paul, W. E., & Seder, R. A. (1994). Lymphocyte responses and cytokines. Cell, 76, 241–251.
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., et al. (2004). Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell, 119, 529–542.
Puls, A., Schmidt, S., Grawe, F., & Stabel, S. (1997). Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proceedings of the National Academy of Sciences of the United States of America, 94, 6191–6196.
Ranganathan, P., & Rangnekar, V. M. (2005). Regulation of cancer cell survival by Par-4. Annals of the New York Academy of Sciences, 1059, 76–85.
Regala, R. P., Weems, C., Jamieson, L., Khoor, A., Edell, E. S., Lohse, C. M., et al. (2005). Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Research, 65, 8905–8911.
Sakurai, T., Maeda, S., Chang, L., & Karin, M. (2006). Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proceedings of the National Academy of Sciences of the United States of America, 103, 10544–10551.
Sanchez, P., De Carcer, G., Sandoval, I. V., Moscat, J., & Diaz-Meco, M. T. (1998). Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Molecular and Cellular Biology, 18, 3069–3080.
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., et al. (2007). IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. The Journal of Clinical Investigation, 117, 3988–4002.
Sanz, L., Diaz-Meco, M. T., Nakano, H., & Moscat, J. (2000). The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. The EMBO Journal, 19, 1576–1586.
Sanz, L., Sanchez, P., Lallena, M. J., Diaz-Meco, M. T., & Moscat, J. (1999). The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. The EMBO Journal, 18, 3044–3053.
Sells, S. F., Wood, D. P., Jr., Joshi-Barve, S. S., Muthukumar, S., Jacob, R. J., Crist, S. A., et al. (1994). Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth and Differentiation, 5, 457–466.
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krahn, G., Bonizzi, G., et al. (2001). Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science, 293, 1495–1499.
Shi, S. H., Jan, L. Y., & Jan, Y. N. (2003). Hippocampal neuronal polarity specified by spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell, 112, 63–75.
Shuai, K., & Liu, B. (2003). Regulation of JAK-STAT signalling in the immune system. Nature Reviews. Immunology, 3, 900–911.
Silverman, N., & Maniatis, T. (2001). NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes and Development, 15, 2321–2342.
Soloff, R. S., Katayama, C., Lin, M. Y., Feramisco, J. R., & Hedrick, S. M. (2004). Targeted deletion of protein kinase C lambda reveals a distribution of functions between the two atypical protein kinase C isoforms. Journal of Immunology, 173, 3250–3260.
Su, H., Bidere, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., et al. (2005). Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science, 307, 1465–1468.
Sumimoto, H., Kamakura, S., & Ito, T. (2007). Structure and function of the PB1 domain, a protein interaction module conserved in animals, fungi, amoebas, and plants. Sci. STKE, 2007 (401) re6, [DOI: 10.1126/stke.4012007re6].
Sun, L., Deng, L., Ea, C. K., Xia, Z. P., & Chen, Z. J. (2004). The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Molecular Cell, 14, 289–301.
Tabuse, Y., Izumi, Y., Piano, F., Kemphues, K. J., Miwa, J., & Ohno, S. (1998). Atypical protein kinase C cooperates with PAR-3 to establish embryonic polarity in Caenorhabditis elegans. Development, 125, 3607–3614.
Tiegs, G., Hentschel, J., & Wendel, A. (1992). A T cell-dependent experimental liver injury in mice inducible by concanavalin A. The Journal of Clinical Investigation, 90, 196–203.
Ventura, J. J., Cogswell, P., Flavell, R. A., Baldwin, A. S., Jr., & Davis, R. J. (2004). JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes and Development, 18, 2905–2915.
Vermeulen, L., De Wilde, G., Damme, P. V., Vanden Berghe, W., & Haegeman, G. (2003). Transcriptional activation of the NF-{kappa}B p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). The EMBO Journal, 22, 1313–1324.
Wodarz, A., Ramrath, A., Kuchinke, U., & Knust, E. (1999). Bazooka provides an apical cue for Inscuteable localization in Drosophila neuroblasts. Nature, 402, 544–547.
Wooten, M. W., Geetha, T., Seibenhener, M. L., Babu, J. R., Diaz-Meco, M. T. and Moscat, J. (2005). The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. The Journal of Biological Chemistry, 280, 35625–35629.
Wooten, M. W., Seibenhener, M. L., Mamidipudi, V., Diaz-Meco, M. T., Barker, P. A., & Moscat, J. (2001). The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. The Journal of Biological Chemistry, 276, 7709–7712.
Xiao, G., Harhaj, E. W., & Sun, S. C. (2001). NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Molecular Cell, 7, 401–409.
Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T., & Gaynor, R. B. (2003). Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature, 423, 655–659.
Yeh, J. H., Sidhu, S. S., & Chan, A. C. (2008). Regulation of a late phase of T cell polarity and effector functions by Crtam. Cell, 132, 846–859.
Zhang, J. Y., Green, C. L., Tao, S., & Khavari, P. A. (2004). NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes and Development, 18, 17–22.
Zhong, H., May, M. J., Jimi, E., & Ghosh, S. (2002). The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Molecular Cell, 9, 625–636.
Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P., & Ghosh, S. (1997). The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell, 89, 413–424.
Zhong, H., Voll, R. E., & Ghosh, S. (1998). Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Molecular Cell, 1, 661–671.
Zhu, J., Min, B., Hu-Li, J., Watson, C. J., Grinberg, A., Wang, Q., et al. (2004). Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nature Immunology, 5, 1157–1165.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Diaz-Meco, M.T., Moscat, J. (2010). Atypical PKCs, NF-κB, and Inflammation. In: Kazanietz, M. (eds) Protein Kinase C in Cancer Signaling and Therapy. Current Cancer Research. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-543-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-543-9_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-542-2
Online ISBN: 978-1-60761-543-9
eBook Packages: MedicineMedicine (R0)